Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Clobetasol, ATC D07AD01
Description
This is not an open procedure, but an open-house model. The form for the open procedure is used only because there is no form for the open-house model. Contracts concluded under the open-house model do not fall under public procurement law due to the lack of a selection decision. The use of this form does not involve submission to public procurement regulations. AOK Bayern intends to conclude non-exclusive discount agreements with all interested pharmaceutical companies for the active substance Clobetasol, ATC D07AD01, in accordance with § 130a (8) SGB V. AOK Bayern offers all interested pharmaceutical companies that meet the eligibility requirements listed below the opportunity to conclude identical and non-individually negotiable discount agreements. The earliest possible contract start date is 01.05.2026, and all contracts end on 30.04.2028. A contract can be concluded at any time during this period, but no later than 03.03.2028. The contracts can be terminated with one month's notice to the end of the month. If a nationwide or state-specific discount contract for medicines with the subject matter of the contract comes into force, the open-house agreements will automatically cease to apply for the corresponding period. A contract will be concluded with all interested pharmaceutical companies that prove their eligibility by completing and signing a self-declaration of reliability. The pharmaceutical company must submit the completed and signed contract (the authorisation of the signatory/s must be evident from the commercial register extract, otherwise a power of attorney must be submitted) together with the completed and signed annex "Specification of the contractual medicines" and the completed and signed self-declaration of reliability. The documents can be submitted EITHER IN WRITING, signed by hand OR ELECTRONICALLY with a qualified electronic signature. Documents signed by hand in writing must be sent in duplicate original to the following address: AOK Bayern - Die Gesundheitskasse Vergabestelle SGB V ZE25 open-house Rabattverträge Carl-Wery-Str. 28 81739 München ELECTRONIC documents with a qualified electronic signature must be submitted via the communications section in the tendering portal www.dtvp.de. If complete and correct documents are received by the 3rd of each month, the contract will commence on the first of the following month, otherwise on the first of the month after next. For documents signed by hand in writing, the complete, completed and signed documents must be sent as a scan to the email address [email protected] or via the communications section in the tendering portal www.dtvp.de in a timely manner, if the complete and correct original documents in paper form are received by AOK Bayern, Vergabestelle, by the 10th of the month. Please note the completion instructions, which are available under www.dtvp.de with the tender documents. Interested pharmaceutical companies can request the release of the tender documents in the project room for the open-house procedure on the portal www.dtvp.de. A link to the portal is included in this notice. Only pharmaceutical companies are considered as potential contracting partners. The documents of the open-house procedure will be released exclusively to pharmaceutical companies as potential contracting partners and must be treated as strictly confidential. By requesting the release, the companies confirm the confidential handling of the documents.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Angiography supplies – Herzkatheterlabor Kreiskliniken Herford-Bünde
Kreiskliniken Herford-Bünde AöRGermanyAngiography suppliesDeadline in 21 daysPublished on Oct 25, 2026
Germany – Radiotherapy, mechanotherapy, electrotherapy and physical therapy devices – Röntgentherapiesystem
Medizinische Universität Lausitz - Carl Thiem KdöRGermanyRadiotherapy, mechanotherapy, electrotherapy and physical therapy devicesDeadline in 8 daysPublished on Oct 25, 2026
Germany – Pharmaceutical products – Patent_95.1_Aripiprazol_Abilify (Maintena)
GWQ ServicePlus AGGermanyPharmaceutical productsDeadline in 32 daysPublished on Oct 25, 2026
Germany – Miscellaneous medical devices and products – Infusionstechnik - Neubau CARDDIAB
Universitätsklinikum DüsseldorfGermanyMiscellaneous medical devices and productsDevices and instruments for infusionInfusion pumpsDeadline in 29 daysPublished on Oct 25, 2026